BIOS Equity Partners III, LP, Director, 10% Owner at ACTUATE THERAPEUTICS, INC. (ACTU), sold 24,999 shares at $9.00 ($225K) on 2024-08-14, disclosed to the SEC on 2024-08-14.
Open-market sale of $225k ACTU by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.00 | 2,324 | $21K | 9.3% |
| 2 | $9.00 | 5,314 | $48K | 21.3% |
| 3 | $9.00 | 17,361 | $156K | 69.4% |
| Total | $9.00 avg | 24,999 | $225K | 100% |